Of Arms and the Law

Navigation
About Me
Contact Me
Archives
XML Feed
Home


Law Review Articles
Firearm Owner's Protection Act
Armed Citizens, Citizen Armies
2nd Amendment & Historiography
The Lecture Notes of St. George Tucker
Original Popular Understanding of the 14th Amendment
Originalism and its Tools


2nd Amendment Discussions

1982 Senate Judiciary Comm. Report
2004 Dept of Justice Report
US v. Emerson (5th Cir. 2001)

Click here to join the NRA (or renew your membership) online! Special discount: annual membership $25 (reg. $35) for a great magazine and benefits.

Recommended Websites
Ammo.com, deals on ammunition
Scopesfield: rifle scope guide
Ohioans for Concealed Carry
Clean Up ATF (heartburn for headquarters)
Concealed Carry Today
Knives Infinity, blades of all types
Buckeye Firearms Association
NFA Owners' Association
Leatherman Multi-tools And Knives
The Nuge Board
Dave Kopel
Steve Halbrook
Gunblog community
Dave Hardy
Bardwell's NFA Page
2nd Amendment Documentary
Clayton Cramer
Constitutional Classics
Law Reviews
NRA news online
Sporting Outdoors blog
Blogroll
Instapundit
Upland Feathers
Instapunk
Volokh Conspiracy
Alphecca
Gun Rights
Gun Trust Lawyer NFA blog
The Big Bore Chronicles
Good for the Country
Knife Rights.org
Geeks with Guns
Hugh Hewitt
How Appealing
Moorewatch
Moorelies
The Price of Liberty
Search
Email Subscription
Enter your email address:

Delivered by FeedBurner

 

Credits
Powered by Movable Type 6.8.8
Site Design by Sekimori

« Interesting legislative move in AZ | Main | So much for the government will protect you »

Chuck Schumer and drug prices

Posted by David Hardy · 22 June 2006 11:01 AM

Off topic, but...

Merck & Co.'s patent on Zocor, a cholesterol-reducing drug, is about to expire. Another company, Teva Pharmaceuticals, began gearing up to bring out a cheaper generic. That's the free market.

Merck cut a deal with an insurance group to reduce its price for Zocor to below the generic price. Okay, that's the free market. They're going to lose the legal monopoly conferred by the patent, and they'd better make their prices competitive.

And so.... Chuck Schumer is calling for an FTC investigation of Merck's price cut.

UPDATE: Here's another patent case involving Teva Pharmaceuticals, in which Schumer filed an amicus brief backing the company's position.

Just did a quick search of the Federal Elections Commission political contributions webpage. Let's see, Harold Snyder, VP of Teva, donated $45,000 to the Democratic Congressional Campaign Committee in 1998-99. In 2001, George Barnett, described as a Teva Executive, gave $2000 to Schumer's election committee. William Fletcher of Teva also gave $2000 to him.

The Demo health plan seems to be -- lowering drug prices is a bad idea, if it hurts Democratic contributors.

1 Comment

T. A. Arnold | July 26, 2006 5:49 AM

I noticed the same irony as you did about Schumer's bias toward TEVA, a foreign-based firm, and against MERCK, a US-based firm, and wondered what's behind his attack on lowering drug prices.